¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"glycogen storage disease type II"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • carcinoid heart disease
    Ä«¸£½Ã³ëÀ̵å½ÉÀ庴
  • Cori¡¯s disease
    ÄÚ¸®º´
  • coronary artery disease
    °ü»óµ¿¸Æº´, ½ÉÀ嵿¸Æº´
  • cadmium worker¡¯s disease
    Ä«µå¹ÅÁ÷°øº´
  • caisson disease
    ÀáÇÔº´
  • counterfeit disease
    ²Òº´
  • Cowden¡¯s disease
    Äڵ纴
  • creeping disease
    ±â´Âº´, ÆÄÇິ
  • Crohn¡¯s disease
    Å©·Ðº´
  • Crouzon¡¯s disease
    Å©·çÁ¾º´
  • Cushing¡¯s disease
    Äí½Ìº´
  • cystic kidney disease
    ³¶¼ºÄáÆÏº´, ³¶¼º½ÅÀ庴
  • cystine disease
    ½Ã½ºÆ¾º´
  • cytomegalic inclusion disease
    °Å´ë¼¼Æ÷Æ÷ÇÔº´, °Å´ë¼¼Æ÷ºÀÀÔüº´
  • cardiovascular disease
    ½É(Àå)Ç÷°üÁúȯ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • chronic granulomatous disease
    ¸¸¼ºÀ°¾ÆÁ¾º´
  • chronic obstructive pulmonary disease
    ¸¸¼ºÆó¼âÆóÁúȯ, ¸¸¼ºÆó¼âÆóº´
  • climatic disease
    ±âÈĺ´
  • cold agglutinin disease
    Àú¿ÂÀÀÁýº´
  • cold hemagglutinin disease
    Àú¿ÂÇ÷±¸ÀÀÁý¼Òº´, ÇÑ·©ÀûÇ÷±¸ÀÀÁýº´
  • collagen disease
    ¾Æ±³Áúº´
  • collagen-vascular disease
    ¾Æ±³ÁúÇ÷°üº´, ±³¿øÇ÷°üº´
  • comb disease
    ´ßº­½½º´
  • combined immunodeficiency disease
    º¹Çո鿪°áÇ̺´
  • combined system disease
    º¹ÇÕ°èÅ뺴
  • combined valvular disease
    º¹ÇÕÆÇ¸·Áõ, º¹ÇÕÆÇ¸·º´
  • communicable disease
    Àü¿°º´
  • communicable disease control
    Àü¿°º´°ü¸®
  • complicating disease
    ÇÕº´Áõ
  • compressed-air disease
    °¡¾Ðº´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • Bernard-Soulier disease
    º£¸£³ª¸£-¼ú¸®¿¡Áúȯ<--º´> ?
  • Bournevilles disease->tuberous sclerosis
    ºÎ¸£³×ºôº´
  • Bowens disease
    º¸À¢ º´
  • Brill-Zinsser disease
    ºê¸±-Áø¼­ Áúȯ
  • Brill-Zinsser disease
    ºê¸±-Áø¼­º´
  • Buergers disease
    ¹ö°Åº´.
  • Burgers disease
    ¹ö°Åº´.
  • COPD=> chronic obstructive pulmonary disease
    ¸¸¼ºÆó»ö(¼â)¼º ÆóÁúȯ(Ø·àõøÍßáàõøËòðü´)
  • Carrions disease
    Ä«¸®¿Âº´.
  • Cavares disease
    Ä«¹Ù·¹º´ ¡ì°¡Á·¼º Áֱ⼺ ¸¶ºñ¡í.
  • Chagas-disease =Brazilian trypano somia sis
    »þ°¡½ºº´ ¡ì¾Æ¸Þ¸®Ä«Æ®¸®ÆÄ ³ë¼Ò¸¶Áõ¡í.
  • Charcot-Guinon disease
    ¼£Äà ±â³í º´
  • Charcot-Marie-Tooth disease
    »þ¸£ÄÚ-¸¶¸®-Åõ½ºº´.
  • Charcots disease
    »þ¸£ÄÚ º´(¡­Ü»).
  • Charlouis-disease
    »þ¸¦·çÀ̺´.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • human T cell leukemia virus type I
    Á¦1Çü »ç¶÷ T¼¼Æ÷¹éÇ÷º´¹ÙÀÌ·¯½º
  • human T cell leukemia virus type II
    Á¦2Çü »ç¶÷ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
  • human T cell leukemia virus type II
    Á¦2Çü »ç¶÷ T¼¼Æ÷¹éÇ÷º´¹ÙÀÌ·¯½º
  • hutchinson-type neuroblastoma
    ÇãÄ£½¼(Hutchinson)Çü ½Å°æ¸ð¼¼Æ÷Á¾
  • hyperlipoproteinemia type III
    °íÁö´Ü¹éÇ÷Áõ III
  • hyperlipoproteinemia type IV
    °í´Ü¹éÇ÷Áõ IV Çü
  • hyperlipoprotenemia type II
    °íÁö´Ü¹éÇ÷Áõ II Çü
  • hyperproteinemia type III
    ´Ü¹é°úÀ×Ç÷(Áõ) III Çü
  • hypersensitivity reactions,delayed-type
    Áö¿¬Çü(òÀæÅû¡)
  • hypersensitivity reactions,type i(anaphylactic)
    IÇü
  • hypersensitivity reactions,type ii(antibody-dependent cell-mediate cyt
    IIÇü
  • hypersensitivity reactions,type iii(imune complex-mediated)
    IIIÇü
  • hypersensitivity reactions,type iv(cell-mediated)
    IVÇü
  • hypersensitivity, delayed-type
    Áö¿¬Çü °ú¹Î¹ÝÀÀ
  • hypersensitivity, immediate-type
    Áï½ÃÇü °ú¹Î¹ÝÀÀ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
ISR information storage and retrieval; Institute for Sex Research; Institute of Surgical Research; insul...
SP sacroposterior; sacrum to pubis; salivary progesterone; schizotypal personality; semi-private [room]...
SPD schizotypal personality disorder; sociopathic personality disorder; specific paroxysmal discharge; s...
STVS short-term visual storage
VIS vaginal irrigation smear; venous insufficiency syndrome; vertebral irritation syndrome; visible; vis...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
AT2 ANG type 2
AAV Adeno-associated virus type 2
AAV-2 Adeno-associated virus type 2
Ad12 Adenovirus type 12
Ad3 Adenovirus type 3
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Azorean disease
    ¾ÆÁ¶·¹º´
    Æ÷¸£Åõ°¥ ¾ÆÁ¶·¹°è °¡Á·¿¡°Ô ¹ß»ýÇÏ´Â ÁßÃ߽Űæ°èÀÇ ÁøÇ༺ º¯¼º Áúȯ. »ó¿°»öü¼º ¿ì¼º ÇüÁú·Î¼­ À¯ÀüÇÏ¸ç ¿©·¯ °¡Áö ÇüÀÌ ÀÖ´Ù. ³× °¡Áö ±âº»ÇüÀÌ ÀÖÀ¸¸ç, Á¦ ¥°ÇüÀº Ãßü ¹× Ãßü¿Ü·ÎÀÇ º¯¼º, Á¦ ¥±ÇüÀº ¼Ò³ú, Ãßü, ¹× Ãßü¿Ü·Î º¯¼º, Á¦ ¥²ÇüÀº ¼Ò³ú º¯¼º°ú ¿øÀ§ºÎ °¨°¢¿îµ¿ ½Å°æº¯Áõ, Á¦ ¥³ÇüÀº ¿øÀ§ºÎ °¨°¢ ½Å°æº´ÁõÀ¸·Î ³ªÅ¸³­´Ù.
  • Baastrup's disease
    ¹Ù½ºÆ®·çÇÁ º´
    µ¿ÀǾî=kissing s
  • Ballet's disease
    ¹ß·¹ º´
    ¿Ü¾È±Ù ¸¶ºñ.
  • Ballingall's disease
    ¹ß¸µ°¥ º´
  • Bamberger's disease
    ¹ãº£¸£°Å º´
    ´Ù¸®ÀÇ µµ¾à °æ·Ã ¶Ç´Â ƽ.
  • Banti's disease
    ¹ÝƼ º´
    Ãʱ⿡´Â ºñÁ¾ ¹× ¹üÇ÷±¸ °¨¼ÒÁõÀ» µ¿¹ÝÇÏ´Â ºñÀåÀÇ ¿ø¹ß¼º ÁúȯÀ¸·Î ±â·ÏµÇ¾úÀ¸³ª, ÈÄ¿¡ ¹®¸Æ¾Ð Ç×Áø¿¡ ÀÇÇÑ ÀÌÂ÷ÀûÀÎ °ÍÀ¸·Î ÀÎÁ¤µÇ¾ú´Ù.
  • Barcoo disease
    ¹Ù¸£Äíº´
    µ¿ÀǾî=desert sore.
  • Barthelemy's disease
    ¹Ù¸£ÅÚ·¹¹Ì º´
    ¾ó±¼ÀÇ °áÇÙ¼º µÎâ ºñ½ÁÇÑ ÁÂâ.
  • Basedow's disease
    ¹Ù¼¼µµ¿ì º´
    µ¿ÀǾî=Graves' disease. °©»ó¼± ±â´ÉÇ×ÁøÁõ.
  • Bazin's disease
    ¹ÙÁø º´
    µ¿ÀǾî=erythema induratum.
  • Beard's disease
    º£¾îµå º´
    µ¿ÀǾî=neurasthenia.
  • Beau's disease
    º¸¿ì º´
    µ¿ÀǾî=cardiac insufficiendy.
  • Bernard-Soulier disease
    º£¸£³ª¸£-¼ú¸®¿¡ º´, Bernard-Soulier º´
    Å©±â¿Í ÇüŰ¡ ´Ù¾çÇÑ Ç÷¼ÒÆÇÀ» Ư¡À¸·Î ÇÏ´Â »ó¿°»öü ¿­¼º À¯Àü¼º ÁúȯÀ¸·Î, Ç÷¼ÒÆÇ ¸·Àº Ç÷Àå vWF
  • Bernhardt's disease
    º£¸¥Çϸ£Æ® º´
    µ¿ÀǾî=meralgia
  • Best's disease
    º£½ºÆ® º´
    µ¿ÀǾî=congenital macular degeneration.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
haemophilus influenzae type b immunization See HIB immunization,
(12 Dec 1998)
Haemophilus influenzae type B vaccine A conjugate of oligosaccharides of the capsular antigen of H. Influenzae type B and diphtheria CRM protein.
(05 Mar 2000)
pre-excitation, mahaim-type A form of pre-excitation characterised by a normal pr interval and a long qrs interval with a delta wave.
(12 Dec 1998)
Hermansky-Pudlak syndrome type VI An autosomal recessive deficiency of pigment in skin, hair, and eyes; in the tyrosinase negative type, there is an absence of tyrosinase; in the tyrosinase positive type, there is normal tyrosinase which cannot enter pigment cells; it is transmitted by an autosomal recessive inheritance. The compound heterozygote is normal so the two forms are not allelic.
There are several types: type IA is characterised by absence of tyrosinase with life-long complete absence of melanin, marked photophobia, and nystagmus. Type IB, yellow albinism with low or absent tyrosinase; improves with age.
Type II, with normal tyrosinase activity is the most common; hair darkens and nevi and freckles develop.
Type III is characterised by absent tyrosinase but pigmentation of the iris in the first decade.
Type IV in Africans with normal tyrosinase.
Type V with red hair.
Type VI, Hermansky-Padlak syndrome, with haemorrhage due to platelet deficiency and low to absent tyrosinase.
Synonym: Hermansky-Pudlak syndrome type VI.
(05 Mar 2000)
herpes simplex type 1 A virus that causes cold sores and fever blisters.
(12 Dec 1998)
herpes simplex type 2 Different from herpes simplex type 1, herpes simplex 2 causes genital herpes.
(12 Dec 1998)
herpes simplex virus type 1 UL13 protein kinase <enzyme> Phosphorylates icp22 and involved in the accumulation of alpha and gamma mrnas and proteins in the infected cells; aa sequence has been determined
Registry number: EC 2.7.1.-
Synonym: ul13 protein kinase, hsv-1, hsv-1 ul13 protein, hsv-1 ul13 pk, u(l)13 protein kinase, protein kinase ul13
(26 Jun 1999)
Schilling type of monocytic leukaemia See: monocytic leukaemia.
(05 Mar 2000)
protoporphyrinogen type III The immediate precursor of protoporphyrin III in haem biosynthesis; elevated in cases of variegate porphyria.
(05 Mar 2000)
protoporphyrinogen type III oxidase A mitochondrial enzyme that uses O2 to convert protoporphyrinogen type III to protoporphyrin type III in haem biosynthesis; a deficiency of this enzyme is associated with variegate porphyria.
(05 Mar 2000)
protoporphyrin type III 2,7,12,18-Tetramethyl-3,8-divinylporphin-13,17dipropionic acid;the principal protoporphyrin found in nature (one of 15 possible isomers), characterised by the presence of 4 methyl groups, 2 vinyl groups, and 2 propionic acid side chains; a porphyrin derivative that, with iron, forms the haem of haemoglobin and the prosthetic groups of myoglobin, catalase, cytochromes, etc.
(05 Mar 2000)
P-type ATPase <enzyme> One of three major classes of ion transport ATPases, characterised by vanadate sensitivity and a phosphorylated intermediate. The archetype is the sodium pump.
See: F-type ATPase, V-type ATPase.
(18 Nov 1997)
H-type fistula <gastroenterology, surgery> A rare form of congenital tracheoesophageal fistula in which there is no oesophageal atresia, manifest as aspiration pneumonias.
Synonym: H-type tracheoesophageal fistula.
(05 Mar 2000)
H-type tracheoesophageal fistula <gastroenterology, surgery> A rare form of congenital tracheoesophageal fistula in which there is no oesophageal atresia, manifest as aspiration pneumonias.
Synonym: H-type tracheoesophageal fistula.
(05 Mar 2000)
serine-type D-Ala-D-Ala carboxypeptidase <enzyme> Cleaves between d-ala residues of bacterial cell wall peptidoglycan; also catalyses transpeptidation of peptidyl-alanyl moieties that are n-acyl substituents of d-alanine
Registry number: EC 3.4.16.4
Synonym: ala-ala carboxypeptidase, serine-type, dd-peptidase, d-alanyl-d-alanine-carboxypeptidase
(26 Jun 1999)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á